245 related articles for article (PubMed ID: 9061303)
1. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
[TBL] [Abstract][Full Text] [Related]
2. Modified hyperinsulinaemic, eu- and hypoglycaemic clamp technique using lispro-insulin for insulinoma diagnostic.
Roudovitch N; Nauck MA; Schatz H; Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2001; 109(8):397-401. PubMed ID: 11748487
[TBL] [Abstract][Full Text] [Related]
3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
4. Suppression of endogenous insulin secretion by exogenous insulin in patients with insulinoma.
Kim CH; Park JY; Shong YK; Hong SK; Kim GS; Lee KU
Clin Endocrinol (Oxf); 2000 Jan; 52(1):87-92. PubMed ID: 10651758
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a euglycaemic clamp procedure as a diagnostic test in insulinoma patients.
Nauck M; Stöckmann F; Creutzfeldt W
Eur J Clin Invest; 1990 Feb; 20(1):15-28. PubMed ID: 1969348
[TBL] [Abstract][Full Text] [Related]
6. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
[TBL] [Abstract][Full Text] [Related]
7. [Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia].
Meier JJ; Hücking K; Grüneklee D; Schmiegel W; Nauck MA
Dtsch Med Wochenschr; 2002 Feb; 127(8):375-8. PubMed ID: 11859446
[TBL] [Abstract][Full Text] [Related]
8. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L
Diabetes; 1995 Jul; 44(7):837-44. PubMed ID: 7789652
[TBL] [Abstract][Full Text] [Related]
9. C-peptide during the prolonged fast in insulinoma.
Service FJ; O'Brien PC; McMahon MM; Kao PC
J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
[TBL] [Abstract][Full Text] [Related]
10. [Hypoglycemic and hyperinsulinemic clamp technic to determine the secretory behavior of insulinoma].
Hütter R; Irsigler K; Vesely M; Ogris E
Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1146-8. PubMed ID: 2839328
[TBL] [Abstract][Full Text] [Related]
11. How reliable is the euglycaemic hyperinsulinemic clamp test for the confirmation of autonomous endogenous hyperinsulinemia?
Mićić D; Popović V; Sumarac M; Kendereski A; Nesović M; Djordjević P; Manojlović D; Mićić J
Exp Clin Endocrinol; 1990 Apr; 95(2):242-50. PubMed ID: 2163878
[TBL] [Abstract][Full Text] [Related]
12. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
Cotterill AM; Holly JM; Amiel S; Wass JA
Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
[TBL] [Abstract][Full Text] [Related]
13. Assessment of hyperinsulinaemia at the termination of the prolonged fast.
Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C
Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285
[TBL] [Abstract][Full Text] [Related]
14. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma.
Hiramatsu S; Sako Y; Mimura K; Ono Y; Iwashige K; Taniguchi S; Umeda F; Nawata H
Endocr J; 1995 Feb; 42(1):39-42. PubMed ID: 7599696
[TBL] [Abstract][Full Text] [Related]
15. Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action.
Vigili de Kreutzenberg S; Riccio A; Dorella M; Avogaro A; Marescotti MC; Tiengo A; del Prato S
Eur J Clin Invest; 1995 May; 25(5):360-7. PubMed ID: 7628524
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemia.
Buffet A; Vezzosi D; Maiza JC; Grunenwald S; Bennet A; Caron P
Eur J Endocrinol; 2013 Jul; 169(1):91-7. PubMed ID: 23657581
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of insulin secretion patterns in insulinoma.
Saddig C; Goretzki PE; Starke AA
World J Surg; 2008 May; 32(5):918-29. PubMed ID: 18259806
[TBL] [Abstract][Full Text] [Related]
18. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma?
Yki-Järvinen H; Pelkonen R; Koivisto VA
Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
Nauck MA; Meier JJ
Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
